AURX

Nuo Therapeutics (QB) (AURX)

Nuo Therapeutics Inc (QB)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:USOTC:AURX

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/23	01:40	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	USOTC:AURX	Nuo Therapeutics Inc (QB)
2024/05/22	04:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:AURX	Nuo Therapeutics Inc (QB)
2024/05/22	04:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:AURX	Nuo Therapeutics Inc (QB)
2024/05/21	21:30	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:AURX	Nuo Therapeutics Inc (QB)
2024/05/16	06:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:AURX	Nuo Therapeutics Inc (QB)
2024/02/15	03:58	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	USOTC:AURX	Nuo Therapeutics Inc (QB)
2024/02/13	07:33	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/12/23	00:01	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/12/21	04:18	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/12/21	04:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/12/21	04:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/12/20	23:02	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/11/21	06:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/11/15	23:37	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/08/09	03:15	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/08/04	05:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/08/04	05:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/08/04	05:15	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/05/16	06:10	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:AURX	Nuo Therapeutics Inc (QB)
2023/04/17	19:08	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:AURX	Nuo Therapeutics Inc (QB)
2022/11/15	08:44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:AURX	Nuo Therapeutics Inc (QB)
2022/11/05	06:28	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:AURX	Nuo Therapeutics Inc (QB)
2022/10/20	21:36	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:AURX	Nuo Therapeutics Inc (QB)
2022/10/20	21:34	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:AURX	Nuo Therapeutics Inc (QB)
2022/08/30	21:16	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:AURX	Nuo Therapeutics Inc (QB)
2022/08/11	02:29	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	USOTC:AURX	Nuo Therapeutics Inc (QB)
2022/08/09	05:49	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:AURX	Nuo Therapeutics Inc (QB)
2022/07/05	21:03	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:AURX	Nuo Therapeutics Inc (QB)
2022/07/05	21:02	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:AURX	Nuo Therapeutics Inc (QB)
2022/07/05	21:02	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:AURX	Nuo Therapeutics Inc (QB)